(Q57271786)
Statements
Phase 1/2 study of fractionated (131)I-rituximab in low-grade B-cell lymphoma: the effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy (English)
Mike Bayne
Nicholas S Brown
Samantha Chilton
Martin J Glennie
Yong Du
James Smart
James Thom
Maureen Zivanovic
12 December 2008